바이오테크 보도자료
-
- PQE Group Launches AI and Data Analytics Division: Innovation in the Service of Life Science
- PQE Group, a leading consultancy in the Life Science sector, announces the consolidation of its new Regulated Artificial Intelligence & Data Analytics division operating since the initiation of AI based tools in the industrial space. This marks a ...
- 06월 27일 13:20
-
- RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors
- RoslinCT, a leading cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), is pleased to announce the appointment of Professor Sir Peter Mathieson MB BS (Hons), PhD, FRCP, FRCPE, FMedSci, FRSE, FRSA and Alexander Vos as ...
- 06월 26일 12:00
-
- Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies
- Takeda (TSE:4502/NYSE:TAK ) today announced that LIVTENCITY® (maribavir) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) for post-transplant cytomegalovirus (CMV) infection/disease that is refractory to existing ant...
- 06월 25일 09:26
-
- Esri Technology Used By ALS Therapy Development Institute to Map Clinical Trials
- The ALS Therapy Development Institute (ALS TDI), a nonprofit biotech dedicated to ending amyotrophic lateral sclerosis (ALS), has used mapping technology from Esri , the global leader in location intelligence, to develop the ALS Trial Navigator. T...
- 06월 23일 16:00
-
- Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
- Takeda (TSE:4502/NYSE:TAK ) today presented positive results from its Phase 2b, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic pri...
- 06월 23일 13:54
-
- PMC Biogenix Announces Expansion and Restructure
- PMC Biogenix, the leading sustainable producer of specialty fatty amides and high-value biobased products, announces the construction and expansion of its new Armoslip® facility in Gyeongju, South Korea allowing for a production capacity increase ...
- 06월 23일 13:40
-
- Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer
- Takeda (TSE:4502/NYSE:TAK ) today announced that the European Commission (EC) approved FRUZAQLA (fruquintinib) as a monotherapy indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated...
- 06월 23일 12:47
-
- QPS Announces New Global Clinical Research Operations Leadership
- QPS, a leading global contract research organization (CRO), is pleased to announce new clinical research operations leadership. This new clinical leadership will further align the existing global medical affairs, regulatory affairs, data services,...
- 06월 21일 13:40
-
- Mary Kay Inc. Presents New Findings on Skin Care Advances and the Use of Computational Tools in Identifying Skin Sensitivity
- Mary Kay Inc. , a global leader in skin care innovation, recently revealed the results of two breakthrough research studies: first, an antioxidant treatment that can diminish the visible effects of pollution and aging on human skin; and second, a ...
- 06월 21일 12:00
전시회
